Multi-Omics Map of Chinese Cervical Cancer Patients Reveals New Drug Targets
An integrated multi-omics study of 112 Chinese cervical cancer patients reveals key driver mutations, immune phenotypes, and promising therapeutic targets.
An integrated multi-omics study of 112 Chinese cervical cancer patients reveals key driver mutations, immune phenotypes, and promising therapeutic targets.
A new preclinical study shows that the β-catenin/CBP inhibitor ICG-001 selectively kills endometrial cancer cells carrying both PIK3CA and CTNNB1 ...
By pairing high-resolution post-mortem MRI with neuropathology in four fetuses at 21 weeks, researchers have captured the earliest stages of ...
A new review maps the recurrent mutations and signaling crosstalk driving gallbladder cancer, identifying ERBB2 and KRAS as hub targets ...
A large single-center analysis finds that metastatic metaplastic triple-negative breast cancer responds less well to sacituzumab govitecan than typical triple-negative ...
A multicenter Italian study of 41 children shows that non-PIK3CA vascular malformations with overgrowth are genetically and clinically so overlapping ...
A new network pharmacology study identifies 14 tea phytochemicals that strongly bind the cancer- and metabolism-linked hub proteins PIK3CA, AKT1, ...
A Swiss genomic study of muscle-invasive bladder cancer finds that oncogene amplifications, rather than tumor mutational burden or microsatellite instability, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine